Enliven Therapeutics Inc. – Filings and Transcripts

NASDAQ: ELVN
Share price (5/22/26): $41.54
Market cap (5/22/26): $2.530 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Automatic shelf registration

Prospectus supplement for primary offering

Addition of securities to prior shelf registration

Ownership Filter

Collins Helen Louise

Collins Helen Louise

Commodore Capital LP

Venrock Healthcare Capital Partners III, L.P.

Polar Capital Holdings Plc

News Filter

Reports First Quarter Financial Results and Provides a Business Update

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

Bolsters Board to Prepare for Next Phase of Development

Announces New CEO to Drive Next Phase of Development

Reports Third Quarter Financial Results and Provides a Business Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission